Walleye Trading’s Syndax Pharmaceuticals SNDX Stock Holding History

Walleye Trading’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-416	Closed	-$9.72K	–	4424
2026 Q1	$9.72K	Buy	+416	New	+$9.04K	﹤0.01%	3941
2025 Q3	–	Sell	-1,940	Closed	-$25.4K	–	4784
2025 Q2	$18.2K	Buy	+1,940	New	+$21.4K	﹤0.01%	3978
2023 Q3	–	Sell	-9,677	Closed	-$203K	–	5333
2023 Q2	$203K	Sell	9,677 -27,018	-74%	-$563K	﹤0.01%	3411
2023 Q1	$775K	Buy	36,695 +25,758	+236%	+$641K	﹤0.01%	2426
2022 Q4	$278K	Buy	+10,937	New	+$255K	﹤0.01%	3310
2022 Q1	–	Sell	-111,382	Closed	-$2.44M	–	5879
2021 Q4	$2.44M	Buy	111,382 +99,783	+860%	+$1.84M	0.01%	1466
2021 Q3	$222K	Buy	+11,599	New	+$193K	﹤0.01%	3756
2019 Q2	–	Sell	-11,172	Closed	-$59K	–	4462
2019 Q1	$59K	Buy	+11,172	New	+$63.7K	﹤0.01%	3671

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

VIG

Vienna Insurance Group Warsaw, Poland $381M AUM 105.39% 1-Year Est. Return

Walleye Trading's SNDX Position: Q2 2026 in Review

Walleye Trading sold out of Syndax Pharmaceuticals (SNDX) in Q2 2026, closing a stake of 416 shares — an estimated $9.72K sold.

Walleye Trading first reported a position in SNDX in Q1 2019 and held it in 8 quarters. The position peaked at $2.44M in Q4 2021. 67 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

Walleye Trading reported no remaining Syndax Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Walleye Trading sold 416 Syndax Pharmaceuticals shares in Q2 2026, an estimated $9.72K.
Walleye Trading first reported a position in Syndax Pharmaceuticals in Q1 2019 and held it in 8 quarters.
Walleye Trading's Syndax Pharmaceuticals position peaked at $2.44M in Q4 2021.
67 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.